Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

NYSEAM:YMI - Post Discussion

YM BioSciences Inc > Insider in on the deal
View:
Post by daydream1 on Mar 12, 2010 8:50am

Insider in on the deal

YM BioSciences Inc. (YM)

As of March 11th, 2010
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Mar 11/10 Mar 10/10 Allan, David G. P. Direct Ownership Warrants 10 - Acquisition in the public market 41,662 $1.600 USD
Mar 11/10 Jun 19/03 Allan, David G. P. Direct Ownership Warrants 00 - Opening Balance-Initial SEDI Report    
Mar 11/10 Mar 10/10 Allan, David G. P. Direct Ownership Common Shares 10 - Acquisition in the public market 83,333 $1.200 USD


Looks like a promising sign of support for management.

Goodluck
D.
Comment by smokeyjoe on Mar 12, 2010 5:14pm
Well, it's encouraging that SOMEBODY still believes in this.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities